Probing Electrostatic Channeling in Protozoal Bifunctional Thymidylate Synthase-Dihydrofolate Reductase Using Site-directed Mutagenesis*

Chloé E. Atreya {ddagger} §, Eric F. Johnson {ddagger} , Jessica Williamson {ddagger}, Sing-Yang Chang ||, Po-Huang Liang || and Karen S. Anderson {ddagger} **

From the {ddagger}Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520 and the ||Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan

Received for publication, December 12, 2002 , and in revised form, May 16, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study we used site-directed mutagenesis to test the hypothesis that substrate channeling in the bifunctional thymidylate synthase-dihydrofolate reductase enzyme from Leishmania major occurs via electrostatic interactions between the negatively charged dihydrofolate produced at thymidylate synthase and a series of lysine and arginine residues on the surface of the protein. Accordingly, 12 charge reversal or charge neutralization mutants were made, with up to 6 putative channel residues changed at once. The mutants were assessed for impaired channeling using two criteria: a lag in product formation at dihydrofolate reductase and an increase in dihydrofolate accumulation. Surprisingly, none of the mutations produced changes consistent with impaired channeling, so our findings do not support the electrostatic channeling hypothesis. Burst experiments confirmed that the mutants also did not interfere with intermediate formation at thymidylate synthase. One mutant, K282E/R283E, was found to be thymidylate synthase-dead because of an impaired ability to form the covalent enzyme-methylene tetrahydrofolate-deoxyuridate complex prerequisite for chemical catalysis.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Electrostatic channeling is a mechanism proposed based on the crystal structure of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR)1 from Leishmania major that would enable negatively charged dihydrofolate produced at the TS active site to be handed off along a series of solvent-exposed lysine and arginine residues to the DHFR active site, where it is converted to tetrahydrofolate (H4folate) (1).

TS and DHFR are crucial enzymes, found in all species. TS represents the only means of de novo synthesis of 2'-deoxythymidylate (dTMP) for DNA synthesis, via reductive methylation of 2'-deoxyuridate (dUMP) with methylene tetrahydrofolate (CH2H4folate), producing dihydrofolate (H2folate) in the process. DHFR catalyzes the reduction of H2folate by NADPH to generate H4folate, used for one carbon unit transfer reactions in several biochemical processes, including thymidylate, purine, and amino acid biosynthesis. Only in protozoal parasites and some plants however, are TS and DHFR found on the same polypeptide chain, leading to the hypothesis that in these organisms, H2folate may be channeled from the TS active site to that of DHFR, never equilibrating with bulk solution (Fig. 1A). When the crystal structure of L. major TS-DHFR was solved (2.9 Å resolution), a 40 Å "electrostatic highway" across the surface of the protein was proposed as an explanation for how channeling may occur (1, 2). We sought to test the electrostatic channeling hypothesis with two parallel approaches. In this report we present results of mutagenesis of solvent-exposed basic residues comprising the electrostatic highway. In an earlier paper, we reported the findings from targeted molecular docking searches to identify small molecule inhibitors that bind in this region, as a means to block the putative channel (3).



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 1.
Electrostatic channeling by TS-DHFR. A, schematic: electrostatic channeling directly transfers the TS product, H2folate, across the surface of the protein to the DHFR active site; whereas in the absence of channeling, H2folate leaves TS, equilibrates with bulk solution, and rebinds at the DHFR site. B, structure of TS-DHFR from L. major with TS shown in red, DHFR in blue, TS and DHFR ligands in green, and solvent-exposed lysines and arginines in magenta.

 

There are precedents for channeling among bifunctional enzymes, of which tryptophan synthase from Salmonella typhimurium is one of the best characterized examples (410). Tryptophan synthase is an {alpha}2{beta}2 enzyme complex: the {alpha} subunit catalyzes the aldolytic cleavage of indole-3-glycerol phosphate to indole and glyceraldehyde 3-phosphate, whereas the {beta} subunit catalyzes the condensation of indole with serine to form tryptophan. Solution of the crystal structure of tryptophan synthase from S. typhimurium revealed a 25 Å hydrophobic tunnel connecting the active sites (4). There is also kinetic evidence for a conformational change following formation of the aminoacrylate intermediate at the {beta} subunit, which accelerates the rate of catalysis at the {alpha} subunit by ~150-fold (6). Buildup of indole is only observed in single enzyme turnover of the {alpha}{beta} reaction when channeling is obstructed by site-directed mutagenesis (7, 8). Although there is no obvious hydrophobic tunnel through L. major TS-DHFR, there is kinetic evidence for substrate channeling, notably the absence of a lag in product formation at DHFR and a lack of buildup of H2folate (11, 12). Also similar to tryptophan synthase, in bifunctional TS-DHFR, the second enzyme (DHFR) is faster than the first (TS), and there is evidence for domain-domain communication (12).

Steady-state kinetics indicates that there is a lag in formation of the products of the DHFR reaction (NADP and H4folate) when monofunctional TS and DHFR enzymes are combined, but not in the case of bifunctional TS-DHFR from Leishmania tropica (11). This suggests that in the case of the bifunctional enzyme only, H2folate produced at the TS site is transferred directly to the DHFR site, rather than first equilibrating in bulk solvent. Direct evidence for substrate channeling has been obtained by transient kinetic analysis. It was shown by rapid chemical quench that in single enzyme turnover experiments with L. major, there is no lag in H4folate production, and little H2folate accumulation is observed, again suggesting direct transfer of H2folate from TS to DHFR (12).

Prior to this report there was no direct evidence for electrostatic guidance of H2folate as the mechanism by which channeling occurs. There are, however, precedents for electrostatic steering in other enzyme systems (1317), and structural analysis and Brownian dynamics simulation techniques applied to TS-DHFR provide support for the electrostatic channeling hypothesis (1, 18, 19). The crystal structure of L. major TS-DHFR revealed that the two active sites are located on the same face of the protein, separated by a distance of 40 Å. Because H2folate has a charge of –2 and polyglutamylated folate substrates found in nature are even more highly negatively charged, distribution of positively charged amino acids (lysine and arginine) on the surface of TS-DHFR was examined. This elucidated a highly positively charged electrostatic potential surface forming the solvent-exposed path connecting TS and DHFR, with a generally negatively charged surrounding surface (1). In the TS domain, contributors to the positively charged potential are Lys-282, Arg-283, and Arg-287, conserved in all TS species. DHFR is much less conserved than TS, and in the DHFR domain of the L. major bifunctional enzyme there is a 12-amino acid loop not present in Escherichia coli; 6 of these residues are positively charged. The positively charged residues, Lys-66, 67, 72, and 73, and Arg-64 and 74, are solvent-exposed and also take part in the putative channel (Fig. 1B). TS is connected to DHFR by a very short tether; it is predicted that torsional rotation of Arg-287 would position its side chain 10–12 Å from that of Lys-73 in the DHFR domain (1). Brownian dynamics simulation also predicts that in the presence of electrostatic effects, 95% of substrate with charge –2 exiting the TS site would reach the DHFR site, whereas only 6% of substrate would channel in the absence of electrostatics (13).

Although the primary goal of this research was to determine whether solvent-exposed basic residues in the shallow groove region of TS-DHFR participate in electrostatic channeling of H2folate, an ancillary goal was to use TS pre-steady-state burst experiments to ascertain whether these same residues might mediate domain-domain communication, or conformational changes induced upon ligand binding at one active site affect activity at the active site of the other enzyme. One conformational change that is known to occur involves TS catalysis: following ordered substrate binding (dUMP then CH2H4folate), the C terminus of TS closes over the substrates to create an active site cavity shielded from solvent (2025). It is thought that this is followed by the formation of an iminium ion involving the bridge methylene and N4 of CH2H4folate (25). We showed previously, using the wild-type enzyme, that there is a burst in consumption of the cofactor, CH2H4folate, at TS (26). Because it is known that chemistry is rate-limiting at TS, the observation of a burst in CH2H4folate consumption signals the accumulation of a TS intermediate, likely the iminium form of CH2H4folate (2224).

If electrostatic guidance, either via diffuse field effects or by an ordered hand-off mechanism, does account for channeling, or if the basic residues are crucial for domain-domain communication, the channel region could serve as a new drug target in parasites. Targeting the channel between the TS and DHFR in bifunctional enzymes has the potential to produce more specific therapies, with fewer side effects than traditional active site-directed medications, for protozoal diseases including malaria and toxoplasmosis. Previously reported results with eosin B signify an important step toward establishing proof of the principle that the putative channel region of TS-DHFR can serve as a molecular target that when inhibited, results in parasite death (3).

In this report we probe the electrostatic channel hypothesis by mutation of solvent-exposed basic residues predicted to participate in channeling. These TS-DHFR channel mutants are assessed for impaired channeling using two criteria: a lag in product formation at DHFR and increased H2folate accumulation. In addition, pre-steady-state burst experiments are used to examine effects on TS catalysis, and one interesting mutant is investigated further.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals—All buffers and other reagents employed were of the highest chemical purity. Millipore ultrapure water was used for all solutions. CH2H4folate and H2folate were purchased from Schircks Laboratories (Switzerland). H4folate was synthesized by reduction of folic acid with sodium borohydride. Tritium-labeled H2folate and CH2H4folate were synthesized using tritiated folic acid as a starting material. The [3',5'-7,9-3H]folic acid as well as 14C-labeled dUMP and FdUMP (5-fluorodeoxyuridine-5'-[2-14C]monophosphate) were obtained from Moravek Biochemicals (Brea, CA). Tritium-labeled H2folate was chemically prepared from the reduction of folate by sodium hydrosulfite (27). Tritiated CH2H4folate was prepared enzymatically: tritium-labeled H2folate was converted to tritiated H4folate by L. major TS-DHFR + NADPH (DHFR reaction) and condensed with formaldehyde to form CH2H4folate. The natural (6R)-L-CH2H4folate enantiomer was purified by DE52 anion exchange chromatography (Whatman Co.) and used exclusively in the studies. H2folate and CH2H4folate solutions were stored in argon purged vials at –80 °C. NADPH and dUMP were purchased from Sigma; the concentration of NADPH was determined by using a molar extinction coefficient of 6,220 M1 cm1 at 340 nm. Enzyme—The clone of the wild-type bifunctional TS-DHFR enzyme from L. major was a generous gift from C.-C. Kan and D. Matthews, then at Agouron Pharmaceuticals. This clone, harboring the pO2CLSA-4 plasmid in an E. coli Rue 10 expression vector, was used to obtain protein of high purity (>99%) using methods described previously for purification (28). The wild-type protein has both TS and DHFR activities similar to those reported previously (11, 28, 29). Mutations were made using a QuikChange mutagenesis kit (Stratagene). Plasmids containing the desired mutations, as confirmed by nucleic acid sequencing, were used to transform competent BL21 E. coli cells. Preliminary enzyme activity assays were conducted on small scale and full scale growths prior to purification. Large growths, typically 22 liters, were necessary to obtain sufficient protein from the more impaired mutants. Mutation of Lys-73 or Arg-74 led to very low yields of active enzyme (0–0.5 mg/liter) and large amounts of insoluble enzyme by gel analysis of the cell pellet (data not shown). Mutant proteins were purified in a manner similar to that for wild-type.

Enzyme Concentrations—The TS-DHFR protein concentration was estimated spectrophotometrically at 280 nm using an extinction coefficient of 67,800 M1cm1. To rule out the possibility that differences in rates between wild-type and mutant enzymes were a result of having different numbers of functional active sites at the same protein concentration, TS active site titrations were performed. 1 µM 10-propargyl-5,8-dideazafolate (PDDF), a folate analog that binds at the TS active site, was titrated with enzyme, and the change in intensity of a fluorescence resonance energy transfer (FRET) peak at 396 nm was recorded on a SLM 4800 fluorometer (Urbana, IL) with the excitation set at 280 nm. Active site titrations were carried out by adding enzyme in small aliquots to minimize any dilution effects and with constant stirring in a 3-ml quartz cuvette at 25 °C. Fluorescence measurements were recorded as an average of four 10-s readings within 15–30 s of enzyme addition, and the recorded fluorescence intensities were corrected for dilution (29). The inflection point of the curve, obtained by plotting intensity versus enzyme concentration, approximates the amount of enzyme required to fully bind 1 µM PDDF, 1 µM wild-type L. major TS-DHFR, R64Q/R283E, and K282E/R283E fully bound 1 µM PDDF. When the starting concentration of PDDF was doubled (2 µM), the inflection point occurred when 2 µM wild-type L. major TS-DHFR had been added (Fig. 2).



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 2.
Active-site concentration of L. major wild-type and K282E/R283E TS-DHFR measured by titrating 1 µM or 2 µM PDDF with enzyme. Recorded as intensity of the PDDF FRET peak at 396 nm as a function of enzyme concentration. The inflection point when 1 µM PDDF is titrated with either wild-type (•) or the K282E/R283E mutant ({blacktriangledown}) is found near 1 µM enzyme, whereas the inflection point is close to 2 µM when wild-type TS-DHFR is titrated with 2 µM PDDF ({blacksquare}), indicating that TS active site concentration is similar to the protein concentration.

 

Enzyme Activity Assays—The DHFR activity was determined by following the decrease in absorbance at 340 nm which accompanies the conversion of substrates NADPH and H2folate to products NADP and H4folate (= –12.8 mM1 cm1) as described previously. The TS activity was monitored by following the increase in absorbance at 340 nm which accompanies the conversion of substrates dUMP and CH2H4folate to dTMP and H2folate (= 6.4 mM1 cm1) (8).

Steady-state Spectroscopic Assays—The steady-state reaction was monitored spectroscopically using a procedure similar to that in Meek et al. (11), who observed a lag in formation of the products of the DHFR reaction (NADP and H4folate) when monofunctional TS and DHFR enzymes are combined, but not in the case of bifunctional TS-DHFR from L. tropica, suggesting that in the case of the bifunctional enzyme only H2folate produced at the TS site is transferred directly to the DHFR site. The predicted change in absorbance is very small, therefore a 10-cm path length quartz observation cell was used to enhance sensitivity. The assay mixture (25 ml) containing buffer (50 mM Tris, pH 7.8, 1 mg/ml bovine serum albumin, 1 mM EDTA, 5 mM H2CO, 75 mM {beta}-mercaptoethanol), 10 nM enzyme, and 28 µM CH2H4folate was incubated with 20 µM NADPH until the A340 stabilized, indicating enzymatic consumption of endogenous traces of H2folate. The reaction was then initiated with 100 µM dUMP (final concentration), and the decrease in NADPH absorbance at 340 nm was monitored in the absence of added H2folate. Experiments were performed using a PerkinElmer Lambda 2 UV-visible spectrophotometer and running PECSS (PerkinElmer computerized spectroscopy software) version 4.0.

Rapid Chemical Quench Experiments—The rapid quench experiments were performed using a Kintek RFQ-3 Rapid Chemical Quench Apparatus (Kintek Instruments, Austin, TX). The single enzyme turnover reaction was initiated by mixing the 15-µl enzyme solution (enzyme + 2 x reaction buffer: 1 mM EDTA, 50 mM MgCl2, 50 mM Tris, at pH 7.8) with the tritiated substrates (15 µl, approximately 20,000 dpm); in all cases, the concentrations of enzyme and substrates cited in the text are those after mixing. The TS-DHFR single enzyme turnover reaction was monitored by the addition of tritiated CH2H4folate to enzyme + NADPH and dUMP. The DHFR reaction was monitored by the addition of tritiated H2folate to enzyme + NADPH. The TS reaction was also monitored under burst conditions: 100 µM enzyme + saturating dUMP, mixed with 200 µM tritiated CH2H4folate. The enzymatic reactions were terminated by quenching with 67 µl of 0.78 N KOH to give a final concentration of 0.54 N KOH (12). TS reactions utilizing radiolabeled dUMP were quenched with 67 µl of 0.4 N HCl. The rate constants for individual single turnover rapid chemical or burst quench experiments were estimated by fitting the data to a single exponential or burst curve using the curve fitting program, Kaleidagraph.

High Performance Liquid Chromatography (HPLC) Analysis—Tritiated products of the rapid quench experiments were quantified by HPLC in combination with a radioactivity flow detector. The HPLC separation was performed using a BDS-Hypersil C18 reverse phase column (250 x 4.6 mm, Keystone Scientific, Bellefonte, PA) with a flow rate of 1 ml/min. An isocratic separation using a solvent system of 10% methanol in 180 mM triethylammonium bicarbonate at pH 8.0 was employed. The elution times were as follows: H4folate, 9 min; H2folate, 18 min; CH2H4folate, 20 min. For separation of dUMP and dTMP, an isocratic separation using a solvent system of 200 mM triethylammonium bicarbonate was used. The elution times were as follows: dUMP, 11 min; dTMP 21.5 min. The HPLC effluent from the column was mixed with liquid scintillation mixture (Monoflow V, National Diagnostics) at a flow rate of 5 ml/min. Radioactivity was monitored continuously using a Flo-One radioactivity flow detector (Packard Instruments, Downers Grove, IL). The analysis system was automated using a Waters 712B WISP (Milford, MA) autosampler.

Stopped-flow Absorbance/Fluorescence Measurements—Stopped-flow measurements were performed using a Kintek SF-2001 apparatus (Kintek Instruments) as described previously (12). In the absorbance experiments designed to measure the burst in CH2H4folate consumption in the TS reaction, absorbance at 340 nM was monitored when 25 µM enzyme was preincubated with 1 mM dUMP and buffer (1 mM EDTA, 50 mM MgCl2, 50 mM Tris, at pH 7.8) and then mixed with 500 µM CH2H4folate.

In the fluorescence experiments designed to measure the dissociation rate constants, the trapping ligand (L2) was used at a concentration of >=5-fold excess over that of L1 to allow for analysis as a pseudo-first-order rate constant. In experiments involving enzyme and PDDF, the monochromator was set at 287 nm on the input, and the FRET was monitored with an interference filter at 380 nm. The data were collected over a given time interval using a personal computer and software provided by Kintek Instruments. Rate constants were obtained by fitting the data to a single or double exponential by nonlinear regression analysis.

Spin Column Binding Assay—Bio-Spin P-30 columns (Bio-Rad) were washed with 10 mM Tris and twice with 1x reaction buffer. Columns were loaded with 30 µlof50 µM enzyme + ligands in reaction buffer and spun for 1 min at 2,000 rpm. An additional 30 µl of reaction buffer was added to the column, and the spin step was repeated. It was shown by UV absorbance that virtually all of the enzyme added to the column was recovered in the flow-through. The amount of enzyme-bound radiolabeled ligand in the flow-through was quantified by adding the 60-µl flow-through to the 7-ml Ultima Gold scintillation mixture (Packard) and counting on an LS7000 scintillation counter (Beckman). Only 1% of total FdUMP counts came through the column in the absence of enzyme; these background counts were subtracted from the total recovered in the presence of enzyme.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Creation of Channel Mutants—The crystal structure of bifunctional TS-DHFR from L. major revealed a series of solvent-exposed basic residues between the two active sites, residues hypothesized to be responsible for channeling of negatively charged H2folate from TS to DHFR. We sought to test this hypothesis by mutating lysines and arginines thought to make up the channel to either glutamic acid (charge reversal) or alanine or glutamine (charge neutralization). The residues mutated were Lys-282, Arg-283, and Arg-287 in the TS domain and Lys-66, 67, 72 and 73, and Arg-64 and 74 in the DHFR domain. A total of 12 channel mutants were successfully created with up to 6 residues changed at once; 2 mutants contained changes in both the TS and DHFR domains (Table I). Consistently, mutation of Lys-73 or Arg-74 led to very low yields of active enzyme and large amounts of insoluble enzyme, suggesting that these DHFR residues may be important for protein folding/domain stability. Insufficient active enzyme for transient kinetics analysis was recovered from attempts to make the following 3 mutants: R74E, K66E/K67E/K72E/K73E/R64Q/R74Q, and R64Q/K66A/K67A/K72E/K73E. Similarly, attempts to completely remove the 12-amino acid basic loop present in L. major but not E. coli DHFR (residues 62–73 in L. major) did not yield soluble enzyme. By doing large growths (typically 22 liters), however, we were still able to make and test 3 combination mutants that included mutation of Lys-73 (Table I).


View this table:
[in this window]
[in a new window]
 
TABLE I
Relative DHFR and TS-DHFR activity, lag in product formation at DHFR, and H2 folate accumulation by major TS-DHFR charge reversal and charge neutralization mutants

DHFR and TS-DHFR activity is presented as the single turnover rate of the mutant enzyme divided by that of wild-type; a difference of <10% is considered to be like wild-type. Criteria for increased H2 folate accumulation was >5% above that observed with wild-type L. major.

 

Steady-state Spectroscopic Analysis to Assess NADP Production—Meek et al. (11) report a lag in production of NADP via the DHFR-catalyzed reduction of H2folate formed by TS in a coupled assay using Lactobacillus casei monofunctional TS and DHFR. In the case of the L. tropica bifunctional TS-DHFR enzyme, no lag was observed, suggesting that H2folate is channeled directly from TS to DHFR (11). The equation for NADP formation via the DHFR catalyzed oxidation of NADPH and reduction of H2folate produced at TS is

(Eq. 1)
where Km is the Km for H2folate, v1 is the rate of TS (µM/min) under coupled assay conditions, and v2 is the DHFR rate (µM/min) using near saturating substrate concentrations. When the NADP concentration is plotted versus time, the steady-state concentration of H2folate corresponds to v1 Km/v2, and the predicted lag time prior to steady-state H2folate accumulation is Km/v2.

Spectroscopic signal change from NADPH consumption, monitored at 340 nm, depends on H2folate formation at TS and is thus proportional to TS activity, whereas lag time is inversely proportional to DHFR activity. To amplify signal change and lag time, TS activity must be maximized and DHFR activity minimized. With monofunctional enzymes this can be accomplished by adjusting the relative TS:DHFR ratios. The bifunctional enzyme poses a particular challenge, however, because the ratio of TS to DHFR active sites is fixed at 1:1 (or 0.5:1 if TS half-site activity is taken into account), and the ratio of specific activities is 1:5.7 (TS:DHFR) for L. major.

With a Km of 0.6 µM for H2folate and the bifunctional enzyme, the steady-state accumulation of H2folate is fixed at 0.11 µM, near reported the 0.1 µM detection limit (11), and corresponding to an absorbance change of 6.6 x 104 AU ({epsilon}340 for H2folate and TS-DHFR = 6,000 mM1 cm1). Using a standard (1-cm path length) quartz cuvette, we observed unacceptable signal to noise in both absorbance (340 nm) and fluorescence (ex 340 nm; em 450 nm) spectra, so a 10-cm path length quartz observation cell was employed with a PerkinElmer Lambda 2 UV-visible spectrophotometer. Here 10 nM L. major TS-DHFR represents the lower limit of ability to detect clearly signal change from NADPH consumption following H2folate production at TS. 10 nM TS-DHFR corresponds to a lag time of 18 s, also near the lower limit of detection when start and mixing times are accounted for.

Using these conditions we observed a lag with E. coli monofunctional TS + DHFR but not with wild-type L. major TS-DHFR, although one was predicted, supporting the existence of channeling by the bifunctional enzyme (Fig. 3, A and B). The following L. major TS-DHFR mutants were tested under similar conditions: R283E, R287E, R64Q, R74Q, and R64Q/K66A/K67A/R287Q. No convincing evidence of a lag in NADP production was observed with any of these putative channel mutants (Fig. 3, C and D).



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 3.
Steady-state spectroscopic analysis to assess NADP production by E. coli TS + DHFR, L. major TS-DHFR, and the L. major R64Q, K66A, K67A, and R283E mutants. A, a lag in NADP production is observed in the coupled assay with E. coli TS + DHFR at concentrations matching the TS and DHFR activities of 10 nM L. major TS-DHFR. No lag was observed with 10 nM L. major TS-DHFR, however, supporting the existence of substrate channeling by the bifunctional enzyme (B). A lag was also absent in the case of the L. major mutants, R64Q, K66A, K67A, at 10 nM (C) and R283E, tested at 20 nM, because TS-DHFR activity is roughly half that of the wild-type enzyme (D).

 

Single Enzyme Turnover Experiments to Look for a Lag in H4Folate Production and Increased H2Folate Accumulation— Although steady-state kinetic analysis is an indirect method from which one can infer information about the rate-limiting step of an enzymatic reaction, transient kinetics allows one to measure directly individual steps in a kinetic pathway as well as to define the reaction kinetics of intermediate formation. Transient kinetics has several advantages for investigation of substrate channeling because, in principle, this technique enables one to monitor directly chemical catalysis at each active site as well as the transit of the putative intermediate from one active site to another (10, 30). In the case of bifunctional TS-DHFR, transient kinetic analysis was used to look for a lag in H4folate production and increased buildup of H2folate as evidence of impaired channeling.

Single enzyme turnover experiments, which measure the rate of the chemical conversion of substrate to product at the active site under conditions where enzyme concentration is sufficiently high that substrate binding is not rate-limiting, were performed using a rapid chemical quench apparatus. In the case of combination of the E. coli monofunctional TS and DHFR, H2folate concentration rises more rapidly than H4folate, and there is almost no H4folate present at the earliest time points, suggesting a lag in product formation at DHFR (Fig. 4, A and B). Early in the time course, H2folate makes up 44–60% of the tritiated material when equal concentrations of monofunctional E. coli TS and DHFR are combined. Conversely, H4folate is formed from the earliest time points with the wild-type bifunctional TS-DHFR enzyme from L. major (no lag) and only a modest amount of H2folate accumulates, peaking at 14% of tritiated material (Fig. 4, C and D). Note that the E. coli enzymes are faster than L. major TS and DHFR, so overall product formation over the course of 0.1 s is greater.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 4.
TS-DHFR single turnover reaction time courses from E. coli and L. major. A and B, TS and DHFR reactions with monofunctional enzymes: 40 µM E. coli TS + 40 µM E. coli DHFR reacted with 12.5 µM tritiated CH2H4folate. CH2H4folate consumption ({blacksquare}), as well as H2folate and H4folate production are reported ({blacktriangleup} and •, respectively); note maximal H2folate accumulation of 45% of tritiated material (A). B, magnification of the early time course illustrating that in the case of E. coli TS + DHFR, there is a lag in product formation at DHFR. H2folate ({blacktriangleup}) accumulates before significant conversion to H4folate (•). C and D compare with the L. major TS-DHFR reaction, where when 50 µM bifunctional enzyme is reacted with 12.5 µM tritiated CH2H4folate, maximum accumulation of H2folate is 14% of tritiated product ({blacktriangledown}) (C), and H4folate (•) is formed from the earliest time points (D).

 

The putative channel mutants were each evaluated for changes in the rate of the TS-DHFR and DHFR reactions. With each mutant tested, full time courses for both wild-type L. major and the mutant were completed, along with t = 0 and t = 60 s controls. The TS reaction was not evaluated independently because the rate of chemistry for TS is significantly slower than that of DHFR in L. major (2 s1 versus 20 s1), the rate of TS limits and is equivalent to that of TS-DHFR. To monitor the TS-DHFR reaction, the bifunctional TS-DHFR enzyme (50 µM) was preincubated with saturating concentrations of dUMP and NADPH (500 µM each) and then mixed with a limiting amount of radiolabeled CH2H4folate (12.5 µM). To monitor the DHFR reaction, the bifunctional TS-DHFR enzyme (50 µM) was preincubated with a saturating concentration of NADPH (500 µM) and then mixed with a limiting amount of radiolabeled H2folate (12.5 µM).

The data in Table I are presented as the ratio of the rate constant obtained for the mutant enzyme divided by that of wild-type; a difference of less than 10% is considered to be like wild-type. The TS mutants R283E and R287E were both found to have approximately half of wild-type TS-DHFR activity, with no impairment of DHFR alone; K282E/R283E was found to be TS-dead, again with no impairment of DHFR. DHFR mutants including R64Q tended to have a slightly faster TS-DHFR rate and a significantly faster DHFR rate. No differences in behavior were observed between charge reversal and charge neutralization mutants.

Representative TS-DHFR and DHFR time courses from the R64Q/K66A/K67A/R287Q mutant are presented in Fig. 5. The R64Q/K66A/K67A/R287Q mutant is slower overall, so at the earliest time points both products (H2folate and H4folate) are below detectable limits, but H4folate is visualized as soon as product is detected (no lag) (Fig. 5B). Although peaking later in the slower, mutant enzyme, the amplitude of maximal H2folate accumulation is the same for the mutant and wild-type TS-DHFR enzymes. Surprisingly, no lag in H4folate production or buildup of H2folate beyond that observed with wild-type L. major was seen with any of the mutants (Table I).



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 5.
Representative TS-DHFR and DHFR reactions: the R64Q/K66A/K67A/R287Q mutant. 50 µM wild-type or mutant enzyme was reacted with 12.5 µM tritiated substrate. A, TS-DHFR reaction. The mutant L. major TS-DHFR enzyme exhibits 45% of wild-type activity, as measured by the rate of formation of H4folate (wild-type, solid lines and closed circles; mutant, dashed lines and open circles). A comparable accumulation of H2folate is observed with wild-type and mutant enzyme (wild-type, solid lines and closed triangles; mutant, dashed lines and open triangles). B, magnification of the early R64Q/K66A/K67A/R287Q mutant time course: at the earliest time points both products are below detectable limits, but H4folate ({circ}) is visualized as soon as product is detected (no lag). {square}, CH2H4folate; {circ}, H2folate. C, the mutant enzyme exhibits 100% of wild-type DHFR activity, as measured by the rate of formation of H4folate. •, wild-type; {circ}, mutant.

 

Pre-steady-state Burst Experiments to Examine Effect of Mutations on TS Catalysis—Stopped-flow absorbance and rapid chemical quench experiments were performed under pre-steady-state burst conditions (substrate in excess over enzyme) to determine whether the channel residues might participate in conformational change, specifically the domain movement involved in TS catalysis. It is known that chemistry is overall rate-limiting at TS, as demonstrated in Fig. 6A; under pre-steady-state burst conditions, where 25 µM L. major TS-DHFR is preincubated with excess 90 µM [14C]dUMP prior to mixing with a large excess of 250 µM CH2H4folate, the TS reaction occurs at a linear steady-state rate with no burst in [14C]dUMP consumption or [14C]dTMP formation. The absence of a burst confirms that chemistry or a preceding step is rate-limiting in the TS reaction. A pre-steady-state burst is observed for consumption of the cofactor, CH2H4folate; however, signaling formation of a TS intermediate, likely the iminium form of CH2H4folate, for which a step following chemistry (e.g. product release) is rate-limiting (Fig. 6B).



View larger version (12K):
[in this window]
[in a new window]
 
FIG. 6.
TS pre-steady-state burst experiments. A, rapid chemical quench TS burst experiment where 25 µM L. major TS-DHFR is preincubated with excess 90 µM [14C]dUMP prior to mixing with a large excess of 250 µM CH2H4folate. B and C, stopped-flow absorbance at 340 nm was monitored when 25 µM L. major TS-DHFR was preincubated with a large excess of 1 mM dUMP and then mixed with 500 mM CH2H4folate. B, wild-type TS-DHFR. C, the R283E TS-DHFR mutant enzyme.

 

Several of the channel mutants were tested for a burst in CH2H4folate consumption to examine the effect of mutation on TS catalysis. R64Q, R283E, and R287E were tested by rapid chemical quench. R64Q, R64Q/K66A/K67A, R74Q, R283E, and R287E were tested using stopped-flow absorbance. In the case of each of the mutants tested using either technique, a biphasic TS burst with a fast and a slow phase was observed, suggesting that the mutated residues are not critical to TS catalysis. Burst amplitudes were similar for each of the mutants tested, but R283E exhibited a pre-steady-state burst rate that was roughly half of that observed with the wild-type enzyme (33 µM s1 versus 63 µM s1) (Fig. 6C).

Further Characterization of the TS-dead Mutant, K282E/R283E—We sought to determine the molecular mechanism by which the K282E/R283E mutant, with two nonactive site mutations near the folate binding site in TS, is devoid of TS activity. The mutation homologous to K282E in E. coli, K48E, was also found to be TS-dead, but no analysis has been reported (31). As mentioned above, by fluorometry, the concentration of TS active sites capable of binding PDDF with the TS-dead mutant is equivalent to the protein concentration. We examine whether the lack of activity is because of (a) decreased binding affinity for folates, (b) impaired nucleotide binding or inability to form the FdUMP·CH2H4folate·enzyme ternary complex prior to chemistry, or (c) global structural instability.

Binding Affinity for PDDF and CH2H4Folate—Stopped-flow fluorescence was used to measure the binding affinity of K282E/R283E for the folate-analog, PDDF, relative to that of wild-type. The kon was obtained by titrating 100 nM wild-type or mutant TS-DHFR with increasing amounts of PDDF and plotting kobs (s1) versus concentration of PDDF added: kobs = kon [PDDF] + koff (Fig. 7). An independent and more precise way to measure the koff for PDDF is to measure the rate when PDDF is competed with an excess of a ligand that binds at the same site. This was accomplished by competing 5 µM PDDF with 100 µM CH2H4folate in the presence of 200 nM wild-type or TS-dead L. major TS-DHFR. For the wild-type enzyme, koff was found to be 2.6 s1, and kon was 21.3 s1 µM–1; Kd = koff/kon = 122 nM. For the TS-dead mutant, koff was found to be 2.05 s1, and kon was 16.52 s1 µM–1; so the Kd for PDDF was 124 nM (Fig. 7). The wild-type and TS-dead enzymes also had a similar koff for CH2H4folate (200 nM enzyme + 5 M CH2H4folate, competed with 50 µM PDDF): for wild-type TS-DHFR, the koff for CH2H4folate was found to be 5.83 s1, and it was 4.1 s1 for the TS-dead mutant.



View larger version (12K):
[in this window]
[in a new window]
 
FIG. 7.
Stopped-flow fluorescence experiment to measure the binding affinity of the K283E/R283E mutant for PDDF. A, representative stopped-flow trace of fluorescence at 380 nM versus time, observed upon mixing K282E/R283E TS-DHFR with 2.5 µM PDDF. B, plot of concentration-dependent rate (kobs) versus PDDF concentration.

 

FdUMP Binding and FdUMP·CH2H4Folate·Enzyme Ternary Complex Formation—Size exclusion columns were used to investigate binding of 14C-labeled FdUMP to the enzyme because no fluorescence signal was detected upon addition of dUMP or the analog, FdUMP. FdUMP nucleotide binding was found to be similar for the wild-type and TS-dead enzymes. When 20 µM radiolabeled FdUMP was added to either 50 µM wild-type or TS-dead TS-DHFR, a small portion of total counts was recovered in the flow-through, representing enzyme-bound FdUMP. It is thought that the low percent bound is a reflection of the high off rate for FdUMP. When excess cold dUMP (100 µM) was added at the same time as the 14C-labeled FdUMP and enzyme, significantly fewer counts were found in the flow-through, indicating that the FdUMP is able to be competed off by dUMP.

It is known that prior to chemistry, a dUMP·CH2H4-folate·enzyme ternary complex is formed. With the wild-type TS enzyme, FdUMP can be used to trap this ternary complex as a covalent intermediate (12, 20). To assess the ability of the mutant enzyme to form the covalent complex, 50 µM enzyme was preincubated with 100 µM excess unlabeled CH2H4folate and 20 µM radiolabeled FdUMP. In this case, ~60% of the total FdUMP was bound to wild-type enzyme, whereas less than 20% was bound to the TS-dead mutant (Fig. 8). When 100 µM excess unlabeled FdUMP was added to the preincubation mix, ~50% of the total FdUMP added still remained bound to the wild-type enzyme, but only 5% remained bound to the mutant (Fig. 8). These results imply that the K282E/R283E TS-dead mutant is unable to form the covalent dUMP·CH2H4-folate·enzyme complex requisite properly for chemistry to take place.



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 8.
Spin column assays to assess FdUMP binding and covalent (FdUMP·CH2H4folate·enzyme) complex formation by the TS-dead mutant. Percent 14C-labeled FdUMP (*FdUMP) bound to wild-type (black) or mutant (gray) TS-DHFR is reported for various conditions. 1) When 20 µM radiolabeled FdUMP was added to wild-type or 50 µM TS-dead enzyme, a small proportion of total 14C counts was recovered in the flow-through, representing enzyme-bound 14C-labeled FdUMP (12 and 7% of counts in with the wild-type and mutant enzymes, respectively). 2) 14C-labeled FdUMP may be competed off either enzyme with 100 µM excess cold dUMP. 3) Significantly more *FdUMP remains bound to enzyme in the presence of 100 µM excess CH2H4folate, although the mutant does not bind as well as wild-type (~15% versus ~60% of *FdUMP bound). Error bars represent differences observed when the experiment was duplicated. 4) Comparatively less *FdUMP can be competed off wild-type enzyme by cold dUMP in the presence of CH2H4folate, suggesting that a covalent complex is forming, as predicted. Again, a difference is observed between the wild-type and mutant enzymes. 80% of *FdUMP remains bound to the wild-type enzyme in the presence of excess CH2H4folate and dUMP, whereas only 33% remains bound to the K282E/R283E mutant.

 

Restoration of Activity to Assess Global Stability—From studies in E. coli, it is known that TS, which exists as a dimer in most species, exhibits half-the-sites activity, meaning that at any given time, only one half of the TS dimer is kinetically competent (31, 32). In E. coli TS it was shown that the amino acid Arg-126 participates in the catalytic site of the opposite half of the dimer and that a TS dimer in which both Arg-126 residues have been mutated to glutamic acid is TS-dead. When a TS-mutant that is dead because of a mutation outside of the active site is combined with the R126E mutant to form a heterodimer, however, full TS activity is restored. In the heterodimer, one half of the dimer now effectively has two mutations (as Arg-126 contributes to the opposite half), but the TS subunit containing R126E is catalytically active, as a normal Arg-126 has been contributed by the nonactive site mutant.

In E. coli, one TS-dead mutant whose activity can be restored by heterodimerization is K48E, homologous to K282E in L. major (31). We hypothesized that if Lys-282 and Arg-283 were crucial to global stability of the protein, then dissociating the TS dimer and reassociating the K282E/R283E mutant with an active site mutant may not lead to restoration of TS activity. To test whether activity could be restored to K282E/R283E, the equivalent mutation to E. coli R126E was made in L. major TS-DHFR, R380E. The R308E homodimer was shown to be TS-dead by a spectroscopic enzyme activity assay and by rapid chemical quench. When 0.41 µM R380E was incubated with 4.1 µM K282E/R283E in the presence of urea to facilitate subunit exchange (1 M urea, 25 mM KP, pH to 7.5), activity was restored.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
As a direct test of the electrostatic channeling hypothesis in L. major TS-DHFR, 12 putative channel mutants were created: up to 6 amino acids were mutated at once, and 2 mutants contained changes in both the TS and DHFR domains. Both charge neutralization and charge reversal mutants were made. The mutants were evaluated for impaired channeling using two criteria: a lag in product formation at DHFR and increased H2folate accumulation.

The mutants were first analyzed in a steady-state spectroscopic experiment for a lag in production of NADP via the DHFR-catalyzed reduction of H2folate produced at TS. Meek et al. (11) observed a lag in the case a monofunctional TS and DHFR-coupled assay but not with the bifunctional TS-DHFR enzyme, suggesting that in the case of the bifunctional enzyme, H2folate produced at TS is channeled across the surface of the enzyme from TS to DHFR without equilibration into bulk solvent. We observed similar behavior using wild-type monofunctional and bifunctional enzymes; however, no clear lag was observed with any of the putative electrostatic channel mutants, suggesting that at this level of analysis, these mutations were not interfering with channeling behavior.

Because we were close to the limits of detection, however, we were not confident of our ability to detect subtle channeling impairment resulting from mutagenesis using this assay. Single enzyme turnover experiments, which allow for direct monitoring of the active sites, were designed, and radiolabeled substrates were used to enhance sensitivity and ability to quantify H2folate accumulation. The mutants were analyzed under single enzyme turnover conditions by rapid chemical quench for a lag in H4folate production and an increased accumulation of H2folate, evidence that, as a result of disruption of the electrostatic channel, H2folate is now leaving the surface of the enzyme at TS and rebinding the DHFR site after equilibration with bulk solution. A lag in production of H4folate and a large accumulation of H2folate were observed when E. coli monofunctional TS and DHFR were combined at a ratio of 1:1. No lag in H4folate production was observed in the case of the L. major bifunctional TS-DHFR enzyme, and only a small amount of H2folate accumulated, 3-fold less than with E. coli TS + DHFR.

It is unclear whether the H2folate observed with the bifunctional enzyme is formed as a result of full TS catalysis or whether it is a breakdown product of the TS iminium ion intermediate. If it is the product of TS catalysis, it suggests that a small percentage of H2folate dissociates from the wild-type TS-DHFR enzyme and rebinds at DHFR. A much larger accumulation, comparable with that observed with E. coli TS + DHFR, is predicted in the absence of channeling (12). Therefore, what we would like to stress is the 3-fold difference in H2folate accumulation between E. coli TS + DHFR and L. major TS-DHFR. If the putative electrostatic channeling mutants were even partially channeling-impaired, this 3-fold difference provides ample latitude to detect subtle changes. The difference in behavior between monofunctional TS + DHFR and bifunctional TS-DHFR is, however, unchanged by mutation of the putative electrostatic channeling residues; none of the putative channel mutants exhibited a lag in H4folate production or increased H2folate accumulation. Results from single enzyme turnover experiments confirm findings of the steady-state assay: no evidence of impaired channeling was observed with any of the putative electrostatic channeling mutants and monoglutamyl folate substrates.

We also performed TS experiments under pre-steady-state burst conditions to determine whether the solvent-exposed basic residues are involved in conformational changes associated with TS catalysis, specifically formation of the TS iminium ion intermediate. In the case of the wild-type enzyme and each of the charge reversal or charge neutralization mutants tested, we observed a burst in consumption of the cofactor, CH2H4folate at TS (26). Because chemistry is overall rate-limiting at TS (no burst in dUMP consumption or dTMP formation), the observation of a burst in CH2H4folate consumption signifies the presence of a TS intermediate, most likely the iminium form of CH2H4folate. Our results suggest that the putative channel residues are not critical to iminium ion formation. Paralleling our single enzyme turnover findings, the R283E mutant exhibited a burst rate that was roughly half of that observed with the wild-type enzyme, indicating impairment of an early step in the kinetic mechanism.

Additional findings were that mutation of Lys-73 or Arg-74 resulted in largely insoluble protein, suggesting that these residues may play a role in protein folding and that the R64Q mutation resulted in faster rates for both TS and DHFR. It is possible that Arg-64 is involved in domain-domain communication and that its normal role is to limit the rate of the TS reaction, but this has yet to be investigated.

The K282E/R283E mutant was found to be TS-dead. In E. coli, mutation of the residue homologous to K282E alone resulted in a TS-dead enzyme, but no mechanism of inactivation was reported (31). It was predicted that the K282E/R283E mutation would prohibit folate binding at the TS site based on the crystal structure of L. major TS-DHFR (Fig. 9) and because corresponding residues in L. casei are known to participate in polyglutamyl folate binding (1). Surprisingly, binding of CH2H4folate or the folate analog, PDDF, was not impaired in the TS-dead mutant. Instead, our studies suggest that Lys-282 and/or Arg-283 is required for ternary complex formation (FdUMP·CH2H4folate·enzyme) prior to chemistry. Because R283E alone results in 40% TS activity but a normal TS burst, indicating formation of the iminium ion intermediate, it follows that Lys-282 is likely the more critical residue for ternary complex formation. It also appears that there is no global structural disturbance because the TS-dead mutant is able to restore activity to the active site mutant, R380E, when heterodimers are formed. Efforts are currently under way to investigate the structural consequences of this mutation by solving the crystal structure in the presence and absence of ligands.



View larger version (60K):
[in this window]
[in a new window]
 
FIG. 9.
Model of the TS-dead (K282E/R283E) L. major TS-DHFR mutant. TS is in red, DHFR in blue, PDDF in green, and dUMP in yellow. Proximity of the TS mutations to the folate analog, PDDF, at the TS active site is greater than to the dUMP binding site (4.27 Å versus 12.25 Å), leading to the prediction that the K282E/R283E mutant was TS-dead because of impaired folate binding.

 

The site-directed mutagenesis data presented in this study do not support the hypothesis that substrate channeling in the bifunctional TS-DHFR enzyme from L. major occurs via electrostatic interactions between the negatively charged H2folate and a series of lysine and arginine residues on the surface of the protein. It now seems probable that channeling instead occurs in conjunction with domain-domain communication or conformational changes induced by ligand binding at one active site that affect activity at the active site of the other enzyme. We have begun to address the coupling of channeling and communication through investigation of a small molecule inhibitor that binds in the channel region (3). Future research will focus on mechanistic and structural determinants of TS-DHFR domain-domain communication as it relates to substrate channeling with the ultimate goal of developing a nonactive site therapy for protozoal infection.


    FOOTNOTES
 
* This work was supported in part by National Institutes of Health Grant AI 44630 (to K. S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ Supported by National Institutes of Health Medical Scientist Training Program Grant GMO7205. Back

Supported by American Cancer Society Grant RPG-98-027-01-CDD (to K. S. A.). Back

** To whom correspondence should be addressed: Dept. of Pharmacology, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520. Tel.: 203-785-4526; Fax: 203-785-7670; E-mail: karen.anderson{at}yale.edu.

1 The abbreviations used are: TS-DHFR, thymidylate synthase-dihydrofolate reductase bifunctional enzyme (this is a functional designation as dihydrofolate is produced at TS and used at DHFR; elsewhere the bifunctional enzyme is referred to as DHFR-TS because DHFR resides at the N-terminal portion of the bifunctional protein); CH2H4folate, methylene tetrahydrofolate; dTMP, 2'-deoxythymidylate; dUMP, 2'-deoxyuridate; FdUMP, 5-fluorodeoxyuridine-5'-monophosphate; FRET, fluorescence resonance energy transfer; Hsfolate, dihydrofolate; H4folate, tetrahydrofolate; HPLC, high performance liquid chromatography; PDDF, 10 propargyl 1–5,8-dideazafolate. Back


    ACKNOWLEDGMENTS
 
We thank C.-C. Kan and Dave Matthews for the generous gift of plasmid.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Knighton, D. R., Kan, C.-C., Howland, E., Janson, C. A., Hostomska, Z., Welsh, K. M., and Matthews, D. A. (1994) Nat. Struct. Biol. 1, 186–194[Medline] [Order article via Infotrieve]
  2. Stroud, R. M. (1994) Nat. Struct. Biol., 1, 131–134[Medline] [Order article via Infotrieve]
  3. Atreya, C. E., Johnson, E. F., Irwin, J. J., Dow, A., Massimine, K. M., Coppens, I., Stempliuk, V., Beverley, S., Joiner, K. A., Shoichet, B. K., and Anderson, K. S. (2003) J. Biol. Chem. 278, 14092–14100[Abstract/Free Full Text]
  4. Hyde, C. C., Ahmed, S. A., Padlan, E. A., Miles, E. W., and Davies, D. R. (1988) J. Biol. Chem. 263, 17857–17871[Abstract/Free Full Text]
  5. Ovadi, J. (1991) J. Theor. Biol. 152, 1–22[Medline] [Order article via Infotrieve]
  6. Anderson, K. S., Miles, E. W., and Johnson, K. A. (1991) J. Biol. Chem. 266, 8020–8033[Abstract/Free Full Text]
  7. Anderson, K. S., Kim, A. Y., Quillen, J. M., Sayers, E., Yang, X.-J., and Miles, E. W. (1995) J. Biol. Chem. 270, 29936–29944[Abstract/Free Full Text]
  8. Schlichting, I., Yang, X.-J., Miles, E. W., Kim, A. Y., and Anderson, K. S. (1994) J. Biol. Chem. 269, 26591–26593[Abstract/Free Full Text]
  9. Thoden, J. B., Holden, H. M., Wesenberg, G., Raushel, F. M., and Rayment, I. (1997) Biochemistry 36, 6305–6316[CrossRef][Medline] [Order article via Infotrieve]
  10. Anderson, K. S. (1999) Methods Enzymol., 308, 111–145[Medline] [Order article via Infotrieve]
  11. Meek, T. D., Garvey, E. P., and Santi, D. V. (1985) Biochemistry 24, 678–686[Medline] [Order article via Infotrieve]
  12. Liang, P.-H., and Anderson, K. S. (1998) Biochemistry 37, 12195–12205[CrossRef][Medline] [Order article via Infotrieve]
  13. Koppenol, W. H., and Margoliash, E. (1982) J. Biol. Chem. 257, 4426–4437[Abstract/Free Full Text]
  14. Ripoll, D. R., Faerman, C. H., Axelsen, P. H., Silman, I., and Sussman, J. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5128–5132[Abstract]
  15. Tan, R. C., Truong, T. N., McCammon, J. A., and Sussman, J. L. (1993) Biochemistry 32, 401–403[Medline] [Order article via Infotrieve]
  16. Getzoff, E. D., Tainer, J. A., Weiner, P. K., Kollman, P. A., Richardson, J. S., and Richardson, D. C. (1983) Nature 306, 287–290[Medline] [Order article via Infotrieve]
  17. Getzoff, E. D., Cabelli, D. E., Fisher, C. L., Parge, H. E., Viezzoli, M. S., Banci, L., and Hallewell, R. A. (1992) Nature 358, 347–351[CrossRef][Medline] [Order article via Infotrieve]
  18. Elcock, A. H., Potter, M. J., Matthews, D. A., Knighton, D. R., and McCammon, J. A. (1996) J. Mol. Biol. 262, 370–374[CrossRef][Medline] [Order article via Infotrieve]
  19. Elcock, A. H., Huber, G. A., and McCammon, J. A. (1997) Biochemistry 36, 16049–16058[CrossRef][Medline] [Order article via Infotrieve]
  20. Spencer, H. T., Villafranca, J. E., and Appleman, J. R. (1997) Biochemistry 36, 4212–4222[CrossRef][Medline] [Order article via Infotrieve]
  21. Finer-Moore, J., Fauman, E. B., Foster, P. G., Perry, K. M., Santi, D. V., and Stroud, R. M. (1993) J. Mol. Biol. 232, 1101–1116[CrossRef][Medline] [Order article via Infotrieve]
  22. Matthews, D. A., Appelt, K., Oatley, S. J., and Xuong, N. H. (1990) J. Mol. Biol. 214, 923–936[Medline] [Order article via Infotrieve]
  23. Montfort, W. R., Perry, K. M., Fauman, E. B., Finer-Moore, J. S., Maley, G. F., Hardy, L., Maley, F., and Stroud, R. M. (1990) Biochemistry 29, 6964–6977[Medline] [Order article via Infotrieve]
  24. Carreras, C. W., and Santi, D. V. (1995) Annu. Rev. Biochem. 64, 721–762[CrossRef][Medline] [Order article via Infotrieve]
  25. Perry, K. M., Carreras, C. W., Chang, L. C., Santi, D. V., and Stroud, R. M. (1993) Biochemistry 32, 7116–7125[Medline] [Order article via Infotrieve]
  26. Johnson, E. F., Hinz, W., Atreya C. E., Maley, F., and Anderson, K. S. (2002) J. Biol. Chem. 277, 43126–43136[Abstract/Free Full Text]
  27. Blakley, R. L. (1960) Nature 188, 231–232
  28. Grumont, R., Sirawaraporn, W., and Santi, D. V. (1988) Biochemistry 27, 3776–3784[Medline] [Order article via Infotrieve]
  29. Grumont, R., Washtein, W. L., Caput, D., and Santi, D. V. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 5387–5391[Abstract]
  30. Anderson, K. S., and Johnson, K. A. (1990) Chem. Rev. 90, 1131–1149
  31. Maley, F., Pedersen-Lane, J., and Changchien, L. (1995) Biochemistry 34, 1469–1474[Medline] [Order article via Infotrieve]
  32. Saxl, R. L., Changchien, L.-M., Hardy, L. W., and Maley, F. (2001) Biochemistry 40, 5275–5282[Medline] [Order article via Infotrieve]